An anergic, islet-infiltrating T-cell clone that suppresses murine diabetes secretes a factor that blocks interleukin 2/interleukin 4-dependent proliferation.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1992-09-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.89.18.8656PMID 1528876PMCID PMC49979
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Receptor-stimulated death pathway is opened by antigen in mature T cells.

  1991cited by this paper
• Antigen-driven bystander suppression after oral administration of antigens

  1991cited by this paper
• Islet‐infiltrating T cell clones from non‐obese diabetic mice that promote or prevent accelerated onset diabetes

  1991cited by this paper
• Mechanistic studies of transforming growth factor-beta inhibition of IL-2-dependent activation of CD3- large granular lymphocyte functions. Regulation of IL-2R beta (p75) signal transduction.

  1991cited by this paper
• Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity.

  1990cited by this paper
• In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp‐lpr/lpr mouse

  1990cited by this paper
• Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression.

  1990cited by this paper
• A role for clonal inactivation in T cell tolerance to Mls-1a.

  1990cited by this paper
• Interferon gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance

  1990cited by this paper
• T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice

  1989cited by this paper
• T-cell tolerance by clonal anergy in transgenic mice with nonlymphoid expression of MHC class II I–E

  1989cited by this paper
• Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) secreted by cells in culture.

  1989cited by this paper
• Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy.

  1989cited by this paper
• Cyclophosphamide-Induced Diabetes in NOD/WEHI Mice: Evidence for Suppression in Spontaneous Autoimmune Diabetes Mellitus

  1989cited by this paper
• Veto cells.

  1988cited by this paper
• Multiple biological activities are expressed by a mouse interleukin 6 cDNA clone isolated from bone marrow stromal cells.

  1988cited by this paper
• T cell tolerance by clonal elimination in the thymus.

  1987cited by this paper
• Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities.

  1986cited by this paper
• Transfer of Autoimmune Diabetes Mellitus with Splenocytes from Nonobese Diabetic (NOD) Mice

  1986cited by this paper
• The murine transforming growth factor-beta precursor.

  1986cited by this paper
• Unique structure of murine interleukin-2 as deduced from cloned cDNAs

  1985cited by this paper
• Molecular cloning of mouse tumour necrosis factor cDNA and its eukaryotic expression.

  1985cited by this paper
• Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts.

  1984cited by this paper
• Cloning and expression of murine immune interferon cDNA.

  1983cited by this paper
• Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin

  1983cited by this paper
• Breeding of a non-obese, diabetic strain of mice.

  1980cited by this paper
• Continuous proliferation of murine antigen-specific helper T lymphocytes in culture

  1979cited by this paper
• Long term culture of tumour-specific cytotoxic T cells

  1977cited by this paper

• transforming growth factors . Ankylosing spondylitis , IgA , and

  2004cites this paper
• Immunoregulation by cytokines in autoimmune diabetes.

  2003cites this paper
• Approaches to Type 1 Diabetes Prevention by Intervention in Cytokine Immunoregulatory Circuits

  2001cites this paper
• Mechanisms of immune tolerance to food antigens in humans.

  2001cites this paper
• A study of the molecular immunogenetics of type 1 diabetes in man.

  2000cites this paper
• Escape mechanisms in tumor immunity: a year 2000 update.

  2000cites this paper
• Modulation of insulin-dependent diabetes mellitus (IDDM) in NOD mice by autoreactive T cells.

  1997cites this paper
• CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice.

  1997cites this paper
• Escape from host-antitumor immunity.

  1997cites this paper
• Activation of CD8+ T lymphocytes in insulin-dependent diabetes mellitus.

  1997cites this paper
• A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice.

  1997cites this paper
• Manipulation of cytokine networks in transplantation: false hope or realistic opportunity for tolerance?

  1997cites this paper
• The lymphocyte and macrophage profile in the pancreas and spleen of NOD mice: percentage of interleukin-2 and prolactin receptors on immunocompetent cell subsets.

  1996cites this paper
• Checkpoints in the progression of autoimmune disease: lessons from diabetes models.

  1996cites this paper
• Ankylosing spondylitis, IgA, and transforming growth factors.

  1995cites this paper
• Advances in selective immunosuppression.

  1995cites this paper
• T cell activation and anergy to islet cell antigen in type I diabetes.

  1995cites this paper
• Human gamma delta T cells are resistant to induction of anergy but not to induction of cell death in vitro.

  1995cites this paper
• Insulin-dependent diabetes mellitus as a beta-cell targeted disease of immunoregulation.

  1995cites this paper
• Prostaglandin E2 promotes the induction of anergy during T helper cell recognition of myelin basic protein.

  1995cites this paper
• In pursuit of the "holy grail": allograft tolerance.

  1994cites this paper
• I-J revisited: is the I-J genetic restriction in downregulation due to an endogenous superantigen analogous to mammary tumour virus (Mtv)-encoded endogenous superantigen?

  1994cites this paper
• Cytokines and the Th1/Th2 paradigm in transplantation.

  1994cites this paper
• Insulin-dependent diabetes mellitus as an autoimmune disease.

  1994cites this paper
• Regulation of the induction and resolution of granulomatous experimental autoimmune thyroiditis in mice by CD8+ T cells.

  1994cites this paper
• Evidence of CD4 + regulatory T cells in the non-obese diabetic male mouse

  1994cites this paper
• T cell mediated immunosuppression.

  1993cites this paper
• Suppressor cells in transplantation immunology: do recent advances in T cell immunobiology and cytokine networking contribute to the solution of an old conundrum?

  1993cites this paper
• Selective immunosuppression of class II-restricted T cells by MHC class II-binding peptides.

  1993cites this paper
• Following a diabetogenic T cell from genesis through pathogenesis.

  1993cites this paper
• A comparative analysis of the characteristics and function of naturally occurring and drug-induced natural suppressor cells in mice.

  1993cites this paper
• T-cell autoimmunity in type 1 diabetes mellitus.

  1993cites this paper
• Genetic dissection of tolerance.

  1992cites this paper
• Editorial overview Genetic dissection of tolerance

  1992cites this paper